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Summary: A simple quantitative photometric method is described for the determination of serum a-foetopro-
tein using latex particle agglutination in an immunochemical System. This method is based on the quantitative
photometric measurement of agglutination of latex particles coated with antibodies against a-foetoprotein.
The turbidity is measured at a wavelength of 340 nm. Agglutination causes a decrease in absorbance.
Interference by serum constituents, e. g. rheumatoid factors, are avoided by pretreating the serum samples
with buffered polyethylene glycol. Concentrations of 0 to 640 μg/l were used for the Standard curve. Analytical
recoveries were 99.5 to 105.2%. Maximum within and between runs coefficients of Variation were 6.2 and
11.6%. The correlation coefficient of the method with radioimmunoassay (RIA), calculated from results on
117 serum samples, was 0.997, and the regression equation y = 0.99x (RIA) — 7.23.
T . , ^ foetoprotem levels are associated with vanous liverIntroduction ,. .diseases e. g. pninary and secondary liver cancer (12,
α-Foetoprotein (AFP) is a glycopr tein of molecular 13), and tumours, including yolk sac structures (12).
weight 70 000. During embryogenesis it is first synthe- In these cases a-foetoprotein determination may serve
sized by the yolk sac and l ter by the foetal liver of s a diagnostic aid and/or therapeutic monitor.
mammals (1—3). Trace synthesis of α-foetoprotein T ,, . „ ., , , . . , .. f
A.n . . * .t < . J , " * , ι , In the numerous commercially available test kits forstill contmues m children and adults, -and low levels « . " . ... / - D T A \ · +u ^
r' ' . , , , . · , . ,*^ α-foetoprotein radioimmunoassay (RIA) is the mostof α-foetoprotein are detect ble in their sera (4). ., , , Α ΐ " , Ώτ Α , . . ,* ' · - - · — ν ^ widely used method. RIA, however, requires a special
During pregnancy, the quantitation of embryonal a- laboratory with complicated and expensive instru-
foetoprotein in maternal serum and amniotie fluid mentation. In this paper a photometric latex aggluti-
h s been shown to be useful in the detection of nation immunoassay for α-foetoprotein is evaluated
various foetal disorders, including neural tube defects using commercially available reagents. This method
(5 — 8) and congenital nephrosis (9 —11). In such dis- enables the quantification of serum a-foetoprotein
Orders a-foetoprotein concentrations are generally with a normal photometer, an Instrument found in
increased. In the non-pregnant state raised serum a- most laboratories.
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Materials and Methods
Serum samples
For α-foetoprotein (AFP) determination, 97 serum samples
from normal and pathological pregnancies and 20 samples from
patients with liver diseases, which had first been analysed by
radioimmunoassay (RIA-gnostR AFP, Behringwerke AG,
Marburg-Lahn, F. R. G.), were obtained from the Kuopio Uni-
versity Central Hospital, Kuopio, Finland. In addition 24 sera
positive for rheumatoid factor by RapiTexR-RF (Behringwerke
AG) and by Waaler-Rose, obtained from United Laboratories,
Helsinki, Finland, were analysed in order to study nonspecific'
agglutination and its elimination.
Reagents
Lyophilized AFP latex reagent in 0.1 mol/1 glycine-buffered
saline, containing bovine serum albumin 20 g/l, pH 9.2 (anti-
AFP coated latex particles) (14).
Lyophilized AFP-references: delipidized zero level bovine serum
and high level serum, 640 μg/l standardized against WHO AFP
preparation 72/225.
Sample pretreatment solution containing polyethylene glycol
(PEG 6000) 84 g/l in 0.01 mol/1 phosphate-buffered saline, pH
7.4.
Diluting buffer containing Tween 20 0.5 g/l in 0.1 mol/1 glycine-
buffered saline. All these reagents were supplied by. Orion
Diagnostica, Espoo, Finland.
Preparation of α-foetoprotein references
Lyophilized zero level and high level reference were reconsti-
tuted with 2 and l ml of distilled water, respectively. For the
Standard curve the high level reference was diluted with zero
level reference to obtain the concentrations of 0, 10, 20, 40, 80,
320 and 640 μ§/1.
Specimen preparation
Serum samples and references were diluted 5-fold with pretreat-
ment solution, mixed well, allowed to stand and centrifuged
for 5 min (1500#). The supernatant was used in the assay.
Assay procedure
Pretreated reference or sample (25 μΐ) was pipetted into the test
tubes. Latex reagent (50 μΐ) was added, followed by gentle
mixing by hand. After incubation for 30 min at room tempera-
ture, 2 ml of diluting buffer was gently added to the tubes.
After at least 45 min, the absorbances were measured at a
wavelenght of 340 nm against water.
Calculation of α-foetoprotein concentration
The absorbance differences (Δ A) between zero level reference
and other tubes were calculated. A graph with Δ Α for the
references on the Y-axis and the concentration of the references
on the X-axis (logarithmic scaie) was plotted and the sample
concentrations taken from this curve. If the α-foetoprotein
vaiue was higher than that of the highest Standard, the sample
was diluted with a zero level reference and reanalysed.
Instrumentation
Gilford Stasar III spectrophotometer with a low volume
flowthrough cuvette, Gilford Instrument Laboratories Ine
Oberlin, OH 44074, USA.
Results
Reference curve
A typical nonlinear reference curve in the α-foetopro-
tein r nge of 10 — 640 μ§/1 is shown in figure 1. The
antigen excess phenomenon was seen at ά-f etopro-
tein concentration of 5000 μ£/1, a!nd thereafter the
curve declined slowly so that Δ Α of the highest
Standard was not reached at 40 000 μg/l (tab. 1). The
time needed for end-point agglutination was 15—20
min but the reaction time could be extended to 60










Fig. 1. Reference curve for the determination of α-foetoprotein
by quantitative photometric latex agglutination immu^
noassay.








































The linearity of the methpd was tested by serially
diluting a patient sample with the zero level reference.
Different dilutions gave the final results ranging from
33300 to 44000 ^g/l with the mean α-foetoprotein
level of 38 200 μg/l (tab. 1),
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Analytical recovery
α-Foetoprotein recovery after addition to three seruin
samples, with theoretical concentrations covering
most of the r nge of the Standard curve, varied from
99 to 105% (tab. 2).
Reproducibility
The within run precision (CV) was 6.2% at low and
5.1% at high α-foetoprotein concentrations, whereas
the between run precision was 11.6% at low and
6.5% at high α-foetoprotein concentrations (tab. 3).
Elimination of serum interference
Nonspecific macromolecular agglutinators in serum
were eliminated by sample pretreatment with polyeth-
ylene glycol containing buffer. Table 4 shows aggluti-
nation data caused by rheumatoid factors, with predi-
lution of sera by pretreatment solution and saline.
False positive results were seen when those sera were
diluted with saline. By using polyethylene glycol, non-
specific agglutinations were effectively eliminated.
Tab. 2. Analytical recovery of α-foetoprotein in photometric
latex agglutination immunoassay.
oc-Foetoprotein (μ§/1)























Tab. 3. Reproducibility of photometric latex agglutination im-
munoassay for α-foetoprotein.





















*) Detenninations within a day with the same latex Suspen-
sion.
**) Determination on different days with different latex su-
spensions taken from the same lyophilized batch.
Comparison with RIA
A total of 117 serum samples, previously analysed by
RIA and stored at —20 °C, were determined by this
method. The coefflcient of eorrelation was 0.997 and








Fig. 2. Correlation between radioimmunosassay (RIA) and
photometric latex agglutination immunoassay for a-
foetoprotein.
r = 0.997, y = 0.99x (RIA) - 7.23, N = 117.
Tab. 4. Influence of rheumatoid factors on agglutination and





















*) Twenty four sera, all positive in RF-latex test and Waaler-
Rose titres ranging from 45 to 5600, median 240, were
analysed.
**) Nonspecific agglutination.
***) False positive results.
Discussion
The first photometric latex agglutination immunoas-
say for rheumatoid factors has already been described
(15). More recently this method has been developed
for determination of 2-microglobulin in human urine
and serum (16), of C-reactive protein (17) and of
ferritin (18) in human serum. Now it has been applied
to the determination of α-foetoprotein in human
serum. Also, another latex agglutination method,
called a particle counting immunoassay, has been
adapted for the determination of α-foetoprotein (19).
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Many interferences by serum, especially rheumatoid
factor, can interfere in any immunoassay. To avoid
these interferences in latex aggluctination tests, va-
rious methods have been used (15, 19, 20, 21, 22).
False positive values due to rheumatoid factor in
untreated sera were also seen in this work. The non-
specific agglutination was successfully eliminated by
sample pretreatment with buffered polyethylene
glycol.
The antigen excess area was at an -foetoprotein level
beyond 5000 §/1. However, values up to 40000 g/l
gave a higher decrease in absorbance than the highest
Standard. References of zero to 640 g/l cover the
most important measuring ränge for monitoring
pregnancies at risk (6, 23, 24), and for diagnosing
and monitoring hepatoma and teratoma (12, 13) äs
well äs benign liver diseases, cirrhosis and hepatitis
(25-28).
In primary liver cancer serum -foetoprotein concen-
tration may vary from the normal value (below 20
g/l) (4) up to 840000 g/l (13). In cases of suspected
liver cancer serial serum dilutions must be used to
avoid the risk of missing such high -foetoprotein
concentrations due to the antigen excess.
The photometric latex agglutination immunoassay
evaluated in this paper is simple to perform and
relatively rapid, and it is suitable for automation.
Manually, it is possible to analyse 50 sefa in half
a day. The dilution linearity was excellent. Many
disadvantages of radioisotopes iij RIA or enzyme-
conjugates in ELISA are avoided with the use of
unlabelled latex reagents, which can be lyophilized,
and are stable for years. The most important advan-
tage is the ability to measure AFP with a normal
spectrophotometer, equipment availäble in most lab-
oratories. Instrumentation for RIA or particle cotmt-
ing is more complicated and expensive. The speci-
ficity, sensitivity and precision of the results obtained
by the quantitative photometric latex agglutination
immunoassay for -foetoprotein are äs göod äs those
obtained by RIA techniques.
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